Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic dr
about
Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic dr
description
2020 nî lūn-bûn
@nan
2020年の論文
@ja
2020年学术文章
@wuu
2020年学术文章
@zh
2020年学术文章
@zh-cn
2020年学术文章
@zh-hans
2020年学术文章
@zh-my
2020年学术文章
@zh-sg
2020年學術文章
@yue
2020年學術文章
@zh-hant
name
Prevalence of COVID-19 among p ...... ted synthetic antirheumatic dr
@en
type
label
Prevalence of COVID-19 among p ...... ted synthetic antirheumatic dr
@en
prefLabel
Prevalence of COVID-19 among p ...... ted synthetic antirheumatic dr
@en
P1476
Prevalence of COVID-19 among p ...... atic drugs' by Conticini et al
@en
P2093
Carlomaurizio Montecucco
P356
10.1136/ANNRHEUMDIS-2020-217738
P50
P577
2020-05-15T00:00:00Z
P6179
1127649401